Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
7.593M
Cash
5.014M
Avg Qtr Burn
-5.499M
Short % of Float
5.88%
Insider Ownership
12.96%
Institutional Own.
14.05%
Qtr Updated
01/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Bria-IMT™ (SV-BR-1-GM) Details Cancer, Breast cancer | Phase 3 Data readout | |
Bria-OTS™ + tislelizumab Details Breast cancer, Cancer | Phase 1/2 Data readout | |
Bria-PROS+ Details Cancer, Prostate cancer | IND Submission |